Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104051334 | 10405133 | 4 | F | 20110815 | 20160825 | 20140825 | 20160831 | EXP | CA-ROCHE-1454049 | ROCHE | 56.74 | YR | F | Y | 0.00000 | 20160831 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104051334 | 10405133 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 150 MG, EVERY 4 WEEKS | U | 103976 | 150 | MG | SOLUTION FOR INJECTION | ||||||
| 104051334 | 10405133 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | SOLUTION FOR INJECTION | |||||||||
| 104051334 | 10405133 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 150 MG, EVERY 4 WEEKS | U | 103976 | 150 | MG | SOLUTION FOR INJECTION | ||||||
| 104051334 | 10405133 | 4 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 104051334 | 10405133 | 5 | C | BRICANYL | TERBUTALINE SULFATE | 1 | 0 | ||||||||||||
| 104051334 | 10405133 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 | ||||||||||||
| 104051334 | 10405133 | 7 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104051334 | 10405133 | 1 | Asthma |
| 104051334 | 10405133 | 2 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104051334 | 10405133 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104051334 | 10405133 | Asthma | |
| 104051334 | 10405133 | Dyspnoea | |
| 104051334 | 10405133 | Fatigue | |
| 104051334 | 10405133 | Forced expiratory volume decreased | |
| 104051334 | 10405133 | Oropharyngeal pain | |
| 104051334 | 10405133 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104051334 | 10405133 | 1 | 20110815 | 0 | ||
| 104051334 | 10405133 | 2 | 20130409 | 0 | ||
| 104051334 | 10405133 | 3 | 20140905 | 0 |